LRMR

Larimar Therapeutics, Inc.

NasdaqGM · Healthcare

$4.11

+3.27% today

last filing 2026-07-06Pro sees filings in ~15 min

Price

hover · 4 moves explained

11 buys42 8-K

Analyst consensus

$15.11target+267.7%vs $4.11 today

$7.00 low today target$26.00 high

9 analysts · ~12-month consensus · as of Jun 21. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 2 of last 4

Earnings per share · actual vs forecast

Q2 '25+15.6%

−$0.41

exp −$0.49

Q3 '25-44.2%

−$0.61

exp −$0.42

Q4 '25-33.8%

−$0.73

exp −$0.55

Q1 '26+47.9%

−$0.31

exp −$0.59

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Buy	2026-07-08	Hamilton Thomas Edward	Director	7.0%Direct	50,000	$3.34	$166.9K
Buy	2026-03-02	THOMAS FRANK E	Director	71%Direct	5,000	$5.00	$25.0K
Buy	2026-03-02	SHERMAN JEFFREY W	Director	100%Direct	5,000	$5.00	$25.0K
Buy	2026-03-02	Hamilton Thomas Edward	Director	15%Direct	100,000	$5.00	$500.0K
Buy	2026-03-02	Flynn James E	10% owner	32%Indirect	2,000,000	$5.00	$10.00M

Buy

Hamilton Thomas Edward

Director · 7.0% of stake · 2026-07-08

$166.9K

50,000 @ $3.34

Buy

THOMAS FRANK E

Director · 71% of stake · 2026-03-02

$25.0K

5,000 @ $5.00

Buy

SHERMAN JEFFREY W

Director · 100% of stake · 2026-03-02

$25.0K

5,000 @ $5.00

Buy

Hamilton Thomas Edward

Director · 15% of stake · 2026-03-02

$500.0K

100,000 @ $5.00

Buy

Flynn James E

10% owner · 32% of stake · 2026-03-02

$10.00M

2,000,000 @ $5.00

10 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →